Amanote Research
Register
Sign In
Relapses of CMV Retinitis After 2 Years of Highly Active Antiretroviral Therapy
British Journal of Ophthalmology
- United Kingdom
doi 10.1136/bjo.84.10.1203
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Date
October 1, 2000
Authors
N CASSOUX
Publisher
BMJ
Related search
Cytomegalovirus Retinitis After the Initiation of Highly Active Antiretroviral Therapy: A 2 Year Prospective Study
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
HIV-related Morbidity Rate, Thirteen Years After the Introduction of Highly Active Antiretroviral Therapy (1996-2009)
Retrovirology
Virology
Infectious Diseases
Ritonavir-Associated Toxicity Mimicking Retinitis Pigmentosa in an Hiv-Infected Patient on Highly Active Antiretroviral Therapy
Retinal Cases and Brief Reports
Medicine
Ophthalmology
Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients With AIDS in the Era of Highly Active Antiretroviral Therapy
Ophthalmology
Ophthalmology
Progressive Neuropsychiatric Problems Following Institution of Highly Active Antiretroviral Therapy
Sexually Transmitted Infections
Dermatology
Infectious Diseases
Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Do All Patients With CMV Retinitis Require Life Long Anti-CMV Therapy?
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Immune Reconstitution in HIV-1 Infected Patients Treated for Two Years With Highly Active Antiretroviral Therapy
Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal Science
Zoology
Parasitology
Infectious Diseases
Toxicology
Sclerosing Cholangitis by Cytomegalovirus in Highly Active Antiretroviral Therapy Era
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
